🔗 Share this article

Chancellor Reeves has stated she is planning "specific steps to deal with household expense challenges" in next month's financial statement.

Speaking to media outlets, she noted that curbing price rises is a collective task of both the government and the central bank.

The UK's inflation rate is projected to be the most elevated among the G7 industrialized countries this year and the following year.

Potential Utility Cost Measures

Sources suggest the government could intervene to bring down energy bills, such as by slashing the current 5% level of VAT charged on energy supplies.

Another possibility is to lower some of the government charges presently added to bills.

Budgetary Limitations and Analyst Expectations

The government will receive the latest draft from the official forecaster, the OBR, on the start of the week, which will clarify how much space there is for these actions.

The consensus from most experts is that Reeves will have to declare higher taxes or expenditure reductions in order to fulfill her voluntary debt limits.

Previously on the same day, calculations showed there was a £22 billion gap for the chancellor to address, which is at the lower end of forecasts.

"There's a shared task between the Bank of England and the administration to further reduce some of the causes of inflation," Reeves stated to reporters in the US capital, at the yearly gatherings of the IMF and World Bank.

Tax Pledges and International Issues

While a great deal of the attention has been on likely tax increases, the chancellor said the most recent figures from the OBR had not changed her vow to manifesto promises not to increase rates on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with rising international and trade concerns for the Budget revenue measures, likely to be directed on those "wealthiest."

International Economic Disputes

Commenting on concerns about the UK's commercial links with the Asian nation she said: "Our national security invariably are paramount."

Recent announcement by Chinese authorities to tighten trade restrictions on rare earths and other resources that are key for high-technology production led US President the US President to threaten an extra 100% tariff on goods from China, increasing the possibility of an full-scale trade war between the two largest economies.

The US Treasury Secretary described China's move "commercial pressure" and "a international production control attempt."

Questioned on considering the US offer to participate in its conflict with China, the Chancellor said she was "very concerned" by China's actions and urged the Chinese government "to avoid restrictions and restrict access."

She said the action was "damaging for the world economy and generates additional challenges."

"In my view there are sectors where we should challenge Chinese policies, but there are also important opportunities to export to Chinese markets, including banking sector and other sectors of the economy. We've got to achieve that equilibrium right."

The chancellor also stated she was working with other major economies "on our own essential resources approach, so that we are less reliant."

NHS Drug Pricing and Funding

Reeves also admitted that the cost the NHS spends on pharmaceuticals could increase as a result of ongoing talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and investment.

A number of the world's largest drug companies have said in recent statements that they are either delaying or canceling projects in the UK, with some blaming the insufficient payments they are obtaining.

Last month, the government science advisor said the price the NHS spends on medicines would must rise to stop firms and drug research funding departing from the United Kingdom.

The Chancellor stated to media: "We have seen as a result of the pricing regime, that clinical trials, recent pharmaceuticals have not been provided in the United Kingdom in the extent that they are in other EU nations."

"Our aim is to ensure that people getting care from the NHS are able to receive the top essential drugs in the globe. And so we are reviewing this situation, and... aiming to secure more investment into the UK."